Citation APA
Maerevoet, M., Zijlstra, J. J., Follows, G., Casasnovas, R. O., Vermaat, J. J., Kalakonda, N., Goy, A., Choquet, S., Van Den Neste, E., Hill, B., Thieblemont, C., Cavallo, F., De la Cruz, F., Kuruvilla, J., Hamad, N., Jaeger, U., Caimi, P., Gurion, R., Warzocha, K., Bakhshi, S., Sancho, J. M., Schuster, M., Egyed, M., Offner, F., Vassilakopoulos, T., Samal, P., Ku, M., Ma, X., Corona, K., Chamoun, K., Shah, J., Shacham, S., Kauffman, M., & Canales, M. (2021). Survival among patients with relapsed/refractory diffuse large B cell lymphoma treated with single-agent selinexor in the SADAL study. Journal of Hematology & Oncology, 14(1), 111. doi:10.1186/s13045-021-01122-1
Permalink
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/329162